AI assistant
Sending…
NATIONAL RESEARCH CORP — Director's Dealing 2011
May 10, 2011
33341_dirs_2011-05-10_9c929807-0e60-42fd-8c40-1b563f4704e8.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: NATIONAL RESEARCH CORP (NRCI)
CIK: 0000070487
Period of Report: 2011-05-06
Reporting Person: SCHORR PAUL C III (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2011-05-06 | Director Stock Option (Right to Buy) | $34.55 | A | 12000 | Acquired | 2021-05-06 | Common Stock (12000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 522 | Direct |
| Common Stock | 4103.537 | Indirect |
| Common Stock | 1014.002 | Indirect |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Director Stock Option (Right to Buy) | $22.61 | 2016-05-04 | Common Stock (12000) | 12000 | Direct |
| Director Stock Option (Right to Buy) | $25.05 | 2017-05-03 | Common Stock (12000) | 12000 | Direct |
| Director Stock Option (Right to Buy) | $29.87 | 2018-05-02 | Common Stock (12000) | 12000 | Direct |
| Director Stock Option (Right to Buy) | $27.23 | 2019-05-08 | Common Stock (12000) | 12000 | Direct |
| Director Stock Option (Right to Buy) | $26.58 | 2020-05-07 | Common Stock (12000) | 12000 | Direct |
Footnotes
F1: As trustee of the Paul C. Schorr III TTEE for Paul V., Carter Matson, Ainslie B. and Mars S. Schorr Trust.
F2: As trustee of the Schorr Family Trust FBO Helen Hailey Condo, Paul C. Schorr III TTEE.
More from NATIONAL RESEARCH CORP
Capital/Financing Update
2026
May 13
Annual Report
2026
May 8
Proxy Solicitation & Information Statement
2026
May 8
Proxy Solicitation & Information Statement
2026
May 8
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
Apr 28
Annual Report
2026
Apr 28
Regulatory Filings
2026
Apr 28
Earnings Release
2026
Apr 28
Regulatory Filings
2026
Apr 20